Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (2)
  • HDAC
    (2)
  • HIV Protease
    (2)
  • Adenosine Receptor
    (1)
  • Akt
    (1)
  • Antibiotic
    (1)
  • Autophagy
    (1)
  • Dopamine Receptor
    (1)
  • FGFR
    (1)
  • Others
    (8)
TargetMol | Tags By ResearchField
  • Cancer
    (6)
  • Infection
    (3)
  • Immune System
    (1)
  • Nervous System
    (1)
Filter
Search Result
Results for "

T6252

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    10
    TargetMol | All_Pathways
Ipatasertib
RG7440, GDC-0068
T62521001264-89-6
Ipatasertib (GDC-0068) is a selective, ATP-competitive pan-Akt inhibitor that inhibits Akt1 (IC50:5 nM), Akt2 (IC50:18 nM), and Akt3 (IC50:8 nM). Ipatasertib (GDC-0068) can lead to p53-independent PUMA activation by inhibiting Akt, thereby activating FoxO3a and NF-κB simultaneously, directly binding to the PUMA promoter, upregulating PUMA transcription and Bax-mediated intrinsic mitochondrial apoptosis.
  • $39
In Stock
Size
QTY
TargetMol | Citations Cited
TP-16
T625252332972-26-4In house
TP-16 is a novel potent and selective EP4 antagonist that blocks the function of IMCs and enhances cytotoxic T cell-mediated tumor elimination in vivo.
  • $277 TargetMol
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Imidocarb dihydrochloride monohydrate
T62520
Imidocarb dihydrochloride monohydrate is an effective antiprotozoal agent against the parasite B. bovis (IC50: 87 μg/ml).
  • $1,520
10-14 weeks
Size
QTY
A2AAR/HDAC-IN-1
T625212767560-51-8
A2AAR/HDAC-IN-1 (compound 14c) is an orally active, balanced dual inhibitor of A2AAR (Ki: 163.5 nM) and HDAC1 (IC50: 145.3 nM).
  • $1,520
6-8 weeks
Size
QTY
FGFR-IN-4
T625222761211-49-6
FGFR-IN-4 is a potent inhibitor of FGFR with potential applications in cancer disease studies.
  • $2,140
8-10 weeks
Size
QTY
Anticancer agent 40
T625232760658-33-9
Anticancer agent 40 (compound 3e) is a potent anticancer agent with effects on SKBR-3 cells (IC50: 0.94 nM), SKOV-3 cells (IC50: 0.98 nM), PC-3 cells (IC50: 0.96 nM), U-87 cells (IC50: 0.95 nM), and HDF cells (IC50: 2.13 nM).
  • $2,140
8-10 weeks
Size
QTY
Panobinostat lactate
T62524960055-56-5
Panobinostat lactate is a potent, orally active, non-selective HDAC inhibitor with antitumor effects. Panobinostat lactate can be used to study refractory or relapsed multiple myeloma.
  • $1,520
1-2 weeks
Size
QTY
HIV-1 inhibitor-8
T62526
HIV-1 inhibitor-8 is a potent, orally active, low toxicity HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI). HIV-1 inhibitor-8 is capable of acting on WT HIV-1 reverse transcriptase (IC50: 0.081 μM). HIV-1 inhibitor-8 exhibited potent antiviral effects against various HIV-1 strains with EC50 values of 4.44-54.5 nM.
  • $954
10-14 weeks
Size
QTY
INO-1001
T62527501364-82-5
INO-1001 is a potent, selective poly(ADP-ribose) polymerase (PARP) inhibitor with antitumor activity.INO-1001 is a potent radiosensitization enhancer that uses interference with DNA repair mechanisms to enhance radiation-induced cell killing and necrotic cell death.
  • $46
5 days
Size
QTY
Dopamine D3 receptor ligand-1
T62528
Dopamine D3 receptor ligand is a potent, selective, high-affinity compound with 89 times greater selectivity for D3 receptors (Ki: 8 nM) compared to D2 receptors (Ki: 715 nM).
  • $1,520
10-14 weeks
Size
QTY